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To optimize the strategies for population-based pharmacogenetic studies, we extensively analyzed single-nucleotide
polymorphisms (SNPs) and haplotypes in 199 drug-related genes, through use of 4,190 SNPs in 752 control subjects.
Drug-related genes, like other genes, have a haplotype-block structure, and a few haplotype-tagging SNPs (htSNPs)
could represent most of the major haplotypes constructed with common SNPs in a block. Because our data included
860 uncommon (frequency !0.1) SNPs with frequencies that were accurately estimated, we analyzed the relationship
between haplotypes and uncommon SNPs within the blocks (549 SNPs). We inferred haplotype frequencies through
use of the data from all htSNPs and one of the uncommon SNPs within a block and calculated four joint probabilities
for the haplotypes. We show that, irrespective of the minor-allele frequency of an uncommon SNP, the majority
(mean  SD frequency ) of the minor alleles were assigned to a single haplotype tagged by htSNPs0.943 0.117
if the uncommon SNP was within the block. These results support the hypothesis that recombinations occur only
infrequently within blocks. The proportion of a single haplotype tagged by htSNPs to which the minor alleles of
an uncommon SNP were assigned was positively correlated with the minor-allele frequency when the frequency
was !0.03 ( ; [Spearman’s rank correlation coefﬁcient]). The results of simulation studiesP ! .000001 n p 233
suggested that haplotype analysis using htSNPs may be useful in the detection of uncommon SNPs associated with
phenotypes if the frequencies of the SNPs are higher in affected than in control populations, the SNPs are within
the blocks, and the frequencies of the SNPs are 10.03.
Introduction
Responses to drugs vary from subject to subject. The
symptoms in some patients may improve dramatically
during treatment with a given drug, whereas other pa-
tients develop severe adverse reactions to the same com-
pound. The differences in the response to a compound
between individuals is of huge importance (Lazarou et
al. 1998). The individual differences in drug response
are, at least in part, attributable to genetic information,
although the effects of other factors, such as sex, age,
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and disease, are not negligible (Evans and Relling 1999;
Meyer 2000; Evans and McLeod 2003).
Studies of the association between genetic variation
and drug response have entered a new era. Recent rapid
advances in human genome research have enabled re-
searchers to genotype at numerous polymorphic loci,
such as SNP loci, within a short period of time (Ohnishi
et al. 2001; Jurinke et al. 2002). Moreover, ∼4,000,000
of the estimated 10,000,000 common SNPs are already
known (Smigielski et al. 2000; Kruglyak and Nickerson
2001; Hirakawa et al. 2002).
Which polymorphic loci in which genes should be
examined? Once a drug is administered, it is absorbed
and distributed to its site of action, where it interacts
with targets, undergoes metabolism, and is then ex-
creted. Each of these processes could potentially involve
an individual difference in drug response. The genes of
various enzymes responsible for the metabolism of the
exogenous compounds, transporters, and drug targets
should be examined. It is now becoming clear that vir-
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tually every pathway of drug metabolismwill eventually
be found to have genetic variations (Meyer 2000).
When the data from many loci on the human genome
are analyzed to associate genetic variations with phe-
notypes, several aspects of population genetics are re-
quired in addition to those of molecular genetics. Recent
studies of data from many individuals at many SNP loci
have clariﬁed that the human genome has a haplotype
(or linkage disequilibrium [LD]) block structure (Clark
et al. 1998; Collins et al. 1999; Kruglyak 1999). Within
a block, LD is strong, and the number of major hap-
lotypes is limited. Genes related to speciﬁc drugs are
likely to have a similar haplotype block structure.
Knowledge about this structure is available; recent stud-
ies have elucidated that haplotype or diplotype conﬁg-
uration (haplotype combination), rather than SNP ge-
notype, is often the principal determinant of phenotypic
consequences (Horikawa et al. 2000; Hugot et al. 2001;
Judson and Stephens 2001; Ogura et al. 2001; Rioux
et al. 2001). Indeed, haplotype analysis has been useful
in predicting the outcome of drug therapy for a b2-
adrenergic stimulator (Drysdale et al. 2000), metho-
trexate (Urano et al. 2002), and sulfasalazine (Tanaka
et al. 2002).
In the present investigation, we genotyped DNA from
752 individuals, for a total of 4,190 SNPs in 199 genes
that code for enzymes of drug metabolism and trans-
port. On the basis of the knowledge obtained by this
analysis, we aimed to establish the optimal strategy for
such population-based pharmacogenetic studies. Our
questions included which SNPs should be genotyped,
whether haplotype-based methods are useful, how to
detect phenotype-associated uncommon SNPs, and
what sample size is necessary for the detection of sig-
niﬁcance. During the analysis, we found that the hap-
lotype block structure is useful not only for common
SNPs but also for uncommon SNPs within the blocks.
This is because the majority of the minor alleles of each
uncommon SNP are assigned to a single major haplo-
type. We extensively analyzed these assignments, be-
cause this knowledge and the technology to analyze it




The present study was approved by the genome ethics
committee of Tokyo Women’s Medical University and
by that of the Pharma SNP Consortium. The subjects
from whom DNA was obtained were recruited from
volunteers. Informed consent was obtained from each
of the subjects. A total of 1,032 volunteers were re-
cruited, and DNA samples from 752 subjects randomly
selected from among these volunteers were used for the
present study. Among the 752 subjects, 449 were male
and 303 were female. The mean  SD ages of the sub-
jects were years for the men and36.1 11.5 40.6
years for the women.11.3
Genotyping
The Invader assay combines structure-speciﬁc cleav-
age enzymes and a universal ﬂuorescent resonance en-
ergy transfer system (Ohnishi et al. 2001). Allele-speciﬁc
oligonucleotide pairs and invasive probes were designed
and supplied by Third Wave Technologies. The proce-
dures for identifying the SNP genotypes have been pub-
lished elsewhere (Kwiatkowski et al. 1999).
Construction of Haplotype Blocks
We developed our own computer program to con-
struct haplotype blocks; however, the algorithm we im-
plemented was essentially based on methods described
elsewhere (Zhu et al. 2003). A block was constructed
using two steps. In the ﬁrst step, an initial interval within
which all pairwise D′ values were0.9 was constructed.
When haplotypes were inferred within this interval, there
were a few major haplotypes whose frequencies were
5%. The combined frequency of the major haplotypes
was90%. To this initial interval, an adjacent SNP was
added, and the inference of the haplotypes was per-
formed using the adjacent SNP in addition to the SNPs
within the interval. If any additional major haplotype
did not appear by this inference, then the new SNP was
added to the other SNPs to make a new interval. This
procedure was repeated in each of the 5′ and 3′ directions
until the inclusion of an adjacent SNP generated an ad-
ditional major haplotype. The resulting interval spanned
all the SNPs examined except for two, the inclusion of
which increased the number of major haplotypes until
they were deﬁned as a haplotype block. In addition to
the above method for haplotype block construction, we
also used the method of Gabriel et al. (2002) for
comparison.
The inference of the population frequencies of the hap-
lotypes was performed by use of the expectation-max-
imization (EM) algorithm (Excofﬁer and Slatkin 1995;
Long et al. 1995; Kitamura et al. 2002). However, this
method is limited, in that it can handle only 20 loci.
Thus, haplotype-tagging SNPs (htSNPs) were used when
120 loci were involved. In this case, the inference of the
haplotypes was performed by partition-ligation–EM
(Qin et al. 2002), and the number of the SNPs was
reduced by selecting htSNPs that the EM algorithm
could handle.
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Inference of Haplotype Frequencies and Selection
of htSNPs
The inference of haplotypes within a haplotype block
was performed using only the SNPs with minor-allele
frequencies 0.1. For the inference, the EM algorithm
(Excofﬁer and Slatkin 1995; Long et al. 1995) was used
with LDSUPPORT software (Kitamura et al. 2002).
The htSNPs were selected using major haplotypes that
explained either 95% or 90% of all the haplotypes
within a block. The methods used to select htSNPs were
essentially the same as those described elsewhere (Daly
et al. 2001; Johnson et al. 2001; Patil et al. 2001). Spe-
ciﬁcally, we used the phase 2 method of Avi-Itzhak et
al. (2003). The phase 1 method of Avi-Itzhak et al.
(2003) was also used to compare results.
Analysis of the Relationship between Uncommon
SNPs and Major Haplotypes
To describe the relationship between uncommon SNPs
and haplotypes, we had to deﬁne a probability space.
Imagine that there is a haplotype block in which a total
of N linked polymorphic loci are present. Let denoteHi
the ith complete haplotype within the block. Here, a
complete haplotype is deﬁned as a list of N alleles at all
N loci (one allele per locus). The sample space Q is de-
ﬁned as a set of all complete haplotypes in all subjects
in the population. Here, is redeﬁned as a subset of QHi
whose elements are . Let X denote the minor allele atHi
one of N loci within the block. X can be redeﬁned as a
set of all complete haplotypes with X in the lists. Then,
the redeﬁned X becomes a subset of Q. Haplotypes de-
ﬁned only by htSNPs can be interpreted as incomplete
haplotypes. Thus, an incomplete haplotype is deﬁnedAi
as the ith list of alleles at only htSNP loci within the
block. is redeﬁned as a set of complete haplotypesAi
consistent with at htSNP loci. When the above def-Ai
initions are used, a complete haplotype , an incompleteHi
haplotype , and X, the minor alleles of an SNP are allAi
deﬁned as subsets of Q; they are interpreted as events on
the same probability space. The complements of those
events, and , can also be deﬁned. Note that those¯X¯ Ai
concepts are not easily deﬁned or stated otherwise.
The association between an uncommon SNP and the
haplotypes tagged by htSNPs within a block was ana-
lyzed as follows. The inference of the haplotypes was
performed by using the genotypes at all htSNPs and one
of the uncommon SNPs (frequency !0.1) within a block.
The haplotype inference was performed using either
LDSUPPORT (Kitamura et al. 2002) or PHASE (Ste-
phens et al. 2001) software. LDSUPPORT infers, on the
basis of the EM algorithm, both the population hap-
lotype frequencies and the diplotype distribution (the
posterior distribution of diplotype conﬁguration) of each
subject, whereas PHASE uses the Markov chain–Monte
Carlo method and the coalescence model for the infer-
ence of the haplotypes. After the haplotype inference,
the following joint probabilities were obtained for all
: , and . Using such¯ ¯¯ ¯A P(A ,X), P(A ,X), P(A ,X) P(A ,X)i i i i i
estimated probabilities, we could calculate P(A dX) pi
. , the incomplete haplo-¯P(A ,X)/[P(A ,X) P(A ,X)] Ai i i j
type that maximizes , was then selected as theP(A dX)i
incomplete haplotype to which X was assigned. P(X d
and¯A ) p P(A ,X)/[P(A ,X) P(A ,X)] P(A dX) pj j j j j
were calculated as the mea-¯P(A ,X)/[P(A ,X) P(A ,X)]j j j
sures for the assignment of an uncommon SNP to the
incomplete haplotypes. The detailed procedure to ana-
lyze the assignment of an uncommon SNP to the incom-
plete haplotypes will be described in the “Results” sec-
tion, using a block as an example.
Simulation to Detect Phenotype-Associated
Uncommon SNPs with Haplotypes Tagged by htSNPs
The probability of detecting signiﬁcance through use
of instead of X in association studies depends onAj
factors such as , , , and¯ ¯P(X d w) P(X d w) P(A dX)/P(A dX)j j
, the numbers of affected and control subjects,M ,M1 2
where and denote the set of complete haplotypes in¯w w
affected subjects and its complement, respectively. The
algorithm for the simulation is described in appendix A.
Results
Genes and SNPs Included in the Study
We genotyped DNA from 752 Japanese individuals at
4,190 SNPs in 199 genes that are either drug-related genes
or are candidates for being drug-related genes. The list of
the genes, their chromosomal locations, and the number
of SNPs in each gene that we studied is presented as a
Web supplement (Genstat Web site). Among them, 4,153
SNP loci in 193 genes were on autosomes, and 37 SNPs
in 6 genes were X linked. Some of the genes are known
to be associated clinically with drug reactions, whereas
others code for transporters, oxidoreductases, various
transferases, and miscellaneous proteins.
Accuracy of the Data
The SNPs genotyped in the present study were derived
from the results of an SNP discovery in which DNA
from 48 subjects was used (Iida et al. 2001a, 2001b,
2002a, 2002b, 2003; Saito et al. 2002). Among all the
SNPs found by this discovery, 4,190 SNPs that were
successfully subjected to the genotyping procedure, as
described in the “Material and Methods” section, were
used to genotype DNA from 752 subjects. Hardy-Wein-
berg equilibrium was always checked, and data that de-
viated strongly from the equilibrium were either sub-
mitted to retyping or discarded.
For the present study, accuracy of the results was ab-
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solutely necessary, because we constructed haplotypes
on the basis of the accurate genotypes at many loci. In
addition, the accuracy of the genotype data was vital to
assigning the minor alleles of each uncommon SNP to
major haplotypes. Therefore, we ﬁrst evaluated the ac-
curacy of the genotype data. The frequency of typing
errors was empirically 0.0001045, according to data ob-
tained by retyping the samematerials. However, we reev-
aluated the rate of the mistyping as follows, because
retyping can lead to the same errors, given the nature
of the materials. The 752 samples included those from
449 men. These samples should not have had any het-
erozygous loci at X-linked SNPs. The researchers who
performed the genotyping were kept totally blinded to
the sex of each subject from whom the DNA was ob-
tained. There were 37 X-linked SNP loci.When themiss-
ing data were excluded, there were 16,479 X-linked ge-
notypes obtained from men, and, among them, 12 were
heterozygous. Therefore, the frequency of the mistyping
from the homozygous to the heterozygous state was es-
timated to be 0.00073.
The mistyping rate from the heterozygous to the ho-
mozygous state was evaluated as follows. The minor-
allele frequency was estimated for each X-linked locus,
by use of only the data from the apparently homozygous
genotypes from the men. Note that the heterozygous
genotypes at such loci are false and should be excluded.
From those data, the expected proportion of the ho-
mozygous genotypes at X-linked loci for women was
estimated to be 0.9139. On the other hand, the observed
proportion of homozygous genotypes at X-linked loci
for women was 0.9169. The difference between the ob-
served and expected proportions was only 0.0033. We
have already shown that there were few mistypings from
the homozygous to the heterozygous state (∼0.00073).
Therefore, if the mistyping rate from the heterozygous
to the homozygous state was high, the observed pro-
portion of the homozygous genotypes at the female X-
linked loci would be signiﬁcantly higher than the ex-
pected proportion. Thus, although the genotyping error
rates may be still underestimated, the data from both
the retyping experiments and the X-linked loci indicate
that the mistyping rates were very small (!0.001).
Distribution of the Frequencies of SNPs in Autosomes
Although the SNPs included in the present study were
discovered in 96 chromosomes, a considerable number
of SNPs were present at proportions !.01 among the
1,504 autosomal chromosomes. Thus, 898 (21.6%) of
the autosomal SNPs that we examined were present in
percentages !10% among the 1,504 chromosomes. Fig-
ure 1 shows the histogram of the minor-allele frequency
for all 4,153 autosomal SNPs in 1,504 chromosomes.
This is as expected, because even the SNPs with very
low frequencies have a chance to be included in a small
number of samples, given that the sampling is a sto-
chastic process.
Construction of Haplotype Blocks
A haplotype, or LD block, is deﬁned as a sizable region
over which there is little evidence for historical recom-
bination and within which only a few major haplotypes
are observed. Because the deﬁnition of a haplotype block
is somewhat ambiguous, there are some discrepancies
between the intervals of the blocks constructed by dif-
ferent researchers, even when they should span the same
region. In fact, we have constructed haplotype blocks
through use of methods described by Zhu et al. (2003)
and Gabriel et al. (2002). The haplotype blocks con-
structed using these two different methods were a little
different, as will be discussed below. Still, the concept
of the block has many beneﬁts and is expected to be
useful for extracting important information about the
region, using data from association studies. For the con-
struction of haplotype blocks, SNPs with minor-allele
frequencies 10.1 or 10.2 are usually used. However, the
frequencies of SNPs estimated using a small number of
subjects are quite unreliable. In the present study, how-
ever, the frequencies were rather reliable, because they
were estimated using a large number of subjects (752)
from the same homogeneous population.
Among 4,153 autosomal SNPs, only 4,104 SNPs un-
ambiguously mapped to the chromosomal regions were
used for the construction of haplotype blocks. Among
them, the minor-allele frequencies were 0.1 in 3,244
SNPs (common SNPs), whereas they were !0.1 in the
remaining 860 SNPs (uncommon SNPs) (ﬁg. 2). There
are no unequivocal deﬁnitions for “common” and “un-
common” SNPs; however, common and uncommon (or
rare) SNPs denote, throughout the present article,
SNPs with minor-allele frequencies of 0.1 and !0.1,
respectively.
Using the 3,244 common SNPs, we identiﬁed a total
of 356 blocks in 179 autosomal genes. Among the 3,244
common SNPs, 3,132 (96.6%) SNPs were within the
blocks, whereas the remaining 112 (3.5%) SNPs were
out of the blocks (ﬁg. 2). Within the blocks, independent
measures of pairwise LD did not decrease substantially
with distance (data not shown). The mean SD number
of blocks in an autosomal gene was (me-1.93 8.75
dian 1). Some blocks were much larger than others.
Lengths of Blocks and the Regions between Blocks
Among the 356 blocks in autosomes, either the 5′ or
3′ ends of the blocks were the same as the edges of the
regions spanning the sets of examined SNPs in 182
blocks. The apparent ends of such blocks may or may
not be the real ends, because blocks may extend farther.
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Figure 1 Histogram of minor-allele frequencies for autosomal SNPs. The minor-allele frequency was calculated for each autosomal SNP,
and the number of SNPs whose estimated minor-allele frequencies were within an interval is shown.
In the other 174 blocks, neither the 5′ nor the 3′ ends
were the same as the edges of the regions. Among these,
both ends were unambiguously mapped in 97 blocks,
and only those locations were used for estimating the
length of the block. The sizes of the blocks were 0.03–
137.47 kb, with a mean of 13.54 kb (SD 16.88 kb) and
a median of 8.79 kb. The largest block, with a length
of 137.47 kb, extended from OAT2 to ABCC10, and
the second largest block, with a length of 77.45 kb, was
within ALDH1A2.
The sizes of the regions between blocks were also cal-
culated when the SNPs were unambiguously mapped.
The sizes of the regions between the blocks were 0.06–
82,330.88 kb, with a mean of 5,436.68 kb (SD
12,855.24 kb) and a median of 11.83 kb. From these
data, we estimated that the blocks make up ∼0.24% and
∼42.6%, respectively, of the examined sequence when
calculated using the median and average physical dis-
tances of block and interblock regions.
Number of Major Haplotypes within a Block
One of the beneﬁts of the haplotype blocks is that
most of the haplotypes within a block are explained by
a limited number of the major haplotypes, even though
the total number of possible haplotypes within the block
is large. We calculated, for each block, the number of
major haplotypes that explain 90% and 95% of all
the haplotypes within the block. The results showed that
(median 3) and (me-3.4916 1.0613 4.2865 1.5239
dian 4) major haplotypes explained 90% and 95%,
respectively, of all the haplotypes within a block.
Number of htSNPs Required to Represent Major
Haplotypes within a Block
If the number of the major haplotypes that explain
most of the haplotypes within a block is limited, then a
small number of htSNPs are likely to represent such
major haplotypes. We selected htSNPs that represented
all of the major haplotypes for each haplotype block.
When such htSNPs were used, all of the major haplo-
types could be distinguished from each other. This means
that additional markers did not substantially increase
the percentages of the haplotypes explained by the major
haplotypes.
For the major haplotypes that explained 90% of
the haplotypes, the number of htSNPs required was
(median 2), whereas it was2.3680 0.9403 2.9037
(median 3) for those that explained95% of the1.1440
haplotypes. When htSNPs were selected from the 3,132
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Figure 2 Statistics of 4,104 autosomal SNPs
within-block common SNPs, 1,035 htSNPs were required
(ﬁg. 2).
Analysis of the Relationship between Uncommon
SNPs and Major Haplotypes
Because the SNPs that we used were discovered using
DNA from 48 subjects, the majority of the uncommon
SNPs should have been missed. Nonetheless, the pop-
ulation frequencies of some SNPs included in the present
study were low, as is shown in ﬁgure 1, because sampling
is a stochastic process. Note that the frequencies of the
minor alleles of even the uncommon SNPs in our data
are more accurate than those in previous studies, because
our sample size was large. Thus, our data may, for the
ﬁrst time, provide good material with which to examine
comprehensively the relationship between uncommon
SNPs and major haplotypes.
If we deﬁne uncommon SNPs as those with minor-
allele frequencies !0.1, 860 SNPs were uncommon (ﬁg.
2). Among these, 549 (63.8%) were within the blocks,
and the remaining 311 (36.2%) SNPs were out of the
blocks (ﬁg. 2). The assignment of each uncommon SNP
to major haplotypes was examined as described in the
“Material and Methods” section.
We selected one of the uncommon SNPs (frequency
!0.1) from the block, calculated for all valuesP(A dX)i
of i, and selected values of j that gave maximum
, as described in the “Material and Methods”P(A dX)j
section. We selected each of all uncommon SNPs within
the block and calculated .P(A dX)j
The detailed procedure for calculating andP(A dX)j
analyzing the assignment of the minor alleles of an un-
common SNP to htSNP-tagged haplotypes is described
in ﬁgure 3. In this illustration, a block (block 4) in the
DPYD (dihydropyrimidine dehydrogenase) gene was
used as an example.
, thus calculated, was plotted against theP(A d X)j
frequency of the uncommon SNP, , for all uncom-P(X)
mon SNPs within the blocks. Figure 4 shows the rela-
tionship between and . The results indi-P(X) P(A dX)j
cated that, irrespective of , was close to 1P(X) P(A dX)j
in most cases. Thus, the mean  SD for wasP(A dX)j
, and it was 10.9 in 83.9% (459) of the0.943 0.117
uncommon SNPs. These data indicate that, in most
cases, each uncommon SNP is assigned to a single in-
complete haplotype deﬁned by the alleles at htSNPs.
Then, we calculated for all uncommon SNPsP(X dA )j
within the blocks and plotted it against (ﬁg. 5).P(X)
The detailed procedure to calculate is illustratedP(X dA )j
in ﬁgure 3. The results indicated that was posi-P(X dA )j
tively correlated with in the region (P(X) 0 ! P(X) !
; ; [Spearman’s rank correla-0.03 P ! .000001 n p 233
tion coefﬁcient]), whereas it was not in the other region
( ; ; ).0.03  P(X) ! 1 P p .050 n p 314
In the above experiments, we examined the relation-
ship between uncommon SNPs and incomplete haplo-
types through use of the haplotype blocks determined
by a method described elsewhere (Zhu et al. 2003). We
also used the haplotype blocks determined by the other
method (Gabriel et al. 2002) and compared the results.
The total number of blocks determined by the method
of Gabriel et al. (2002) was 420, which is a little larger
than total obtained by using the other method. The
length of the block was kb (0.021–166.3311.01 8.41
kb; median 5.15 kb). Thus, the lengths of the blocks
determined using the method of Gabriel et al. (2002)
were, on average, shorter than those determined using
the method of Zhu et al. (2003). Even though the hap-
Figure 3 Illustration of the procedure for the analysis of the assignment of uncommon SNPs within an LD block to haplotypes tagged
by htSNPs. A, Genotype data from the DPYD (dihydropyrimidine dehydrogenase) gene on 1p. B, Common SNP loci (minor-allele frequencies
0.1) chosen from among all SNP loci and used to construct LD blocks, as described in the “Material and Methods” section. C, Block 4, with
nine common SNPs, was used as an example from among a total of 14 blocks constructed. This block included ﬁve uncommon SNPs in addition
to the nine common SNPs. The htSNPs (“ht”) selected later (E) are also indicated. D, Haplotypes inferred using only the nine common SNPs,
as described in the “Material and Methods” section. A haplotype is expressed as a list of either “1” or “2” alleles, along with the estimated
frequency in the parentheses. E, htSNPs selected from the inferred haplotype data (D), as described in the “Material and Methods” section.
For block 4, loci 2, 6, and 12 (indicated by asterisks in panel D) were selected as htSNPs. F, One of the uncommon SNPs within block 4 (loci
4, 5, 7, 8, or 9 in panel C) chosen for the analysis of the assignment, in addition to the three htSNPs selected. In this case, locus 5 was chosen
as the uncommon SNP. By use of the genotype data from loci 2, 5, 6, and 12, haplotypes were inferred as described in the “Material and
Methods”section. An inferred haplotype was described as a list of either one or two alleles at four SNP loci. In the list, the allele at the
uncommon SNP (locus 5) is shown in parentheses (“u”). There was only one haplotype with (1), the minor allele of the uncommon SNP—that
is, 2(1)12. Therefore, the haplotype 2()12 was judged to be , the htSNP-tagged haplotype to which the majority of the minor alleles of anAj
uncommon SNP were assigned. All haplotypes were categorized according to the presence (X) or absence ( ) of (1) and the presence ( ) orX¯ Aj
absence ( ) of the haplotype 2()12. Thus, there are four categories: (a) (Aj and X), (b) (Aj, not X), (c) (X, not Aj), and (d)¯ ¯¯A A ,X A ,X A ,Xj j j j
(not Aj, not X). The frequencies of the haplotypes in the same category were summed to calculate the estimated probabilities¯ ¯A ,X P(A ,X),j j
, and . For locus 5, the following estimated probabilities were obtained:¯ ¯¯ ¯ ¯P(A ,X), P(A ,X) P(A ,X) P(A ,X) p 0.0266, P(A ,X) p 0.0012,j j j j j
, and . Thus, for locus 5, , thereby indicating that all the minor alleles¯ ¯ ¯¯P(A ,X) p 0 P(A ,X) p 0.9722 P(A dX) p P(A ,X)/[P(A ,X) P(A ,X)] p 1j j j j j j
at locus 5 were assigned to the haplotype 2()12 ( ). G, Locus 8 chosen as the uncommon SNP. By use of the genotype data from loci 2, 6,Aj
8, and 12, haplotypes were inferred as described in the “Material and Methods” section. An inferred haplotype was described as a list of either
one or two alleles at four SNP loci, and the allele at the uncommon SNP (locus 8) is shown in parentheses (“u”). There were only two haplotypes
with (2), the minor allele of the uncommon SNP. By comparing the frequencies, the haplotype 12(2)2, rather than 11(2)1, was judged to be
, the htSNP-tagged haplotype to which the majority of the minor alleles of an uncommon SNP were assigned. All haplotypes were categorizedAj
according to the presence (X) or absence ( ) of (2) and the presence ( ) or absence ( ) of the haplotype 12()2. The frequencies for the¯X¯ A Aj j
haplotypes in the same category were summed to calculate the estimated probabilities , and . For locus 8, the¯ ¯¯ ¯P(A ,X), P(A ,X), P(A ,X) P(A ,X)j j j j
following estimated probabilities were obtained: , and . Thus, for¯ ¯¯ ¯P(A ,X) p 0.0791, P(A ,X) p 0.2585, P(A ,X) p 0.0007 P(A ,X) p 0.6617j j j j
locus 8, , thereby indicating that the majority of the minor alleles at locus 8 were assigned to¯P(A dX) p P(A ,X)/[P(A ,X) P(A ,X)] p 0.991j j j j
the haplotype 12()2 ( ).Aj
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Figure 4 Proportion of minor alleles (X) of an uncommon SNP assigned to a haplotype tagged by htSNPs—that is, . TheA P(A dX)j j
procedure to calculate is described in detail in ﬁgure 3. represents the frequency of the minor allele of an uncommon SNP.P(A dX) P(X)j
lotype blocks determined by the method of Gabriel et
al. (2002) were a little different from those determined
using the method of Zhu et al. (2003), the proportion
of an uncommon SNP assigned to a haplotype—that is,
—was also close to 1 ( for theP(A dX) 0.954 0.114j
data from 353 uncommon SNPs within the blocks).
When uncommon SNPs located outside of the blocks
but adjacent to them were examined for assignment to
the incomplete (htSNP-tagged) haplotypes within the
blocks, the majority of the minor alleles of uncommon
SNPs were not necessarily assigned to single incomplete
haplotypes (data not shown). Therefore, the assignment
of the majority of the minor alleles to single incomplete
haplotypes is a characteristic of uncommon SNPs within
the blocks but not of those outside of the blocks.
When X was ﬁrst generated by a mutation, P(X dA )j
was probably very low, and was probably 1.P(A dX)j
As time goes on, and will increase, andP(X) P(X dA )j
will decrease ifX does not disappear. Therefore,P(A dX)j
the data for and for , whenP(A dX) P(X dA ) P(X) !j j
, reﬂect the status when X was ﬁrst generated.0.03
Probability to Detect Phenotype-Associated
Uncommon SNPs with Haplotypes Tagged by htSNPs
Haplotypes constructed using only htSNPs (incom-
plete haplotypes) are expected to be useful in the iden-
tiﬁcation of major haplotypes. However, it is not clear
how useful htSNPs and incomplete haplotypes are for
the identiﬁcation of uncommon phenotype-associated
SNPs. We studied this problem through use of our hap-
lotype data.
It is known that severe adverse effects from some
drugs can occur in homozygous persons who have en-
zyme deﬁciencies. In those cases, the causative minor
allele X is expected to be elevated in cases—that is,
is expected to be much higher than ,¯P(X d w) P(X d w)
which is low. However, the above condition is not suf-
ﬁcient for incomplete haplotypes to be useful in detecting
X. For the association studies using incomplete haplo-
types but not uncommon phenotype-associated SNPs to
be useful, should be different from )¯P(A dX) P(A dXj j
(see appendix A).
Therefore, we calculated for all X¯P(A dX)/P(A dX)j j
within the blocks and plotted the results against inP(X)
ﬁgure 6. The results indicated that is muchP(A dX)j
higher than in many of the cases, especially¯P(A dX)j
when is 10.02. In fact, the mean  SD ofP(X) P(A dj
was . Therefore, may beX¯)/P(A dX) 0.200 0.230 Aj j
used as a marker of X in many cases in association
studies searching for X.
The probability of detecting signiﬁcance through use
of instead of X in association studies depends onAj
factors such as , , , and¯ ¯P(X d w) P(X d w) P(A dX)/P(A dX)j j
, the sizes of affected and control samples, asM ,M1 2
shown in appendix A. Extensive simulation studies were
performed using various parameter sets to address this
point, as described in the “Material and Methods” sec-
tion and in appendix A.
Figure 7 shows an example of the results of the sim-
ulation. The graph shows the empirical probability
of signiﬁcance (power) of the test when r p P(X d
, , and . The signif-¯w)/P(X d w) p 8 M p 50 M p 5001 2
icance level was set at .01. We extensively examined
the power of the test, through use of different param-
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Figure 5 Proportion of htSNP-tagged haplotype containing minor alleles (X) of uncommon SNPs—that is, . wasA P(X dA ) P(X dA )j j j
calculated using . The procedure to calculate and is described in detail in ﬁgure 3.¯ ¯P(X dA ) p P(A ,X)/[P(A ,X) P(A ,X)] P(A ,X) P(A ,X)j j j j j j
eter sets ( , 0.5, 3, 5, 8, 10, and 15; ,r p 0.2 M p 501
100, and 300; and , 100, and 500). AlthoughM p 502
both the models and the parameter sets that we ex-
amined are still limited, our results suggest that the
phenotype-associated X is likely to be detected by Aj
when , r, , and are sufﬁciently large. ForP(X) M M1 2
example, under the conditions used in ﬁgure 7, the
mean SD power was ( ) when0.239 0.313 n p 233
, but it was ( ) whenP(X) ! 0.03 0.885 0.251 n p 314
. The power depended on and on suchP(X)  0.03 P(X)
parameters as r, , and , and it increased whenM M1 2
either of those parameters or (the frequency ofP(X)
the minor allele of the uncommon SNP) was increased.
Under the conditions used in ﬁgure 7, most of the un-
common SNPs within the blocks can be identiﬁed by
htSNP-tagged haplotypes when the frequencies of the
uncommon SNPs are 10.03.
Discussion
In the present investigation, we estimated the frequen-
cies of SNPs, constructed haplotype blocks, estimated
the frequencies of haplotypes within the blocks, and
selected htSNPs representing the major haplotypes,
through use of genotype data at 4,190 SNPs in 199
drug-related genes from 752 subjects. Thereafter, we
analyzed the association between uncommon SNPs
within the blocks and the haplotypes constructed with
htSNPs. The majority of the minor alleles of the un-
common SNPs were assigned to single major haplo-
types when the uncommon SNPs were within blocks.
The results of simulation studies suggested that hap-
lotype analysis that uses htSNPs may be useful in the
detection of uncommon phenotype-associated SNPs if
(1) the frequencies of the SNPs are higher in affected
populations than in control populations, (2) the SNPs
are within the blocks, and (3) the frequencies of the
SNPs are 10.03.
As stated in the “Material and Methods” section, the
relationship among a haplotype (a complete haplo-Hi
type), a haplotype constructed with htSNPs (an in-Ai
complete haplotype), and the minor allele of an uncom-
mon SNP X within a block can be described by deﬁning
the above concepts as events on the sample space Q, the
set of all complete haplotypes in a population. isAj
deﬁned as the incomplete haplotype for which P(A dj
is the maximum among all for the block. VariousX) Ai
conditional probabilities were calculated from the joint
probabilities , and .¯ ¯¯ ¯P(X,A ), P(X,A ), P(X,A ) P(X,A )j j j j
These joint probabilities were estimated by the haplo-
type-inference algorithm, using genotype data for all of
the htSNPs and an uncommon SNP within a block.
The results of our analysis indicated that wasP(A dX)j
close to 1 in most of the cases, irrespective of , theP(X)
minor-allele frequency of the uncommon SNP (ﬁg. 4).
When X was ﬁrst generated by a mutation, wasP(A dX)j
probably 1. As time goes on, is likely to decreaseP(A dX)j
because of recombination within the blocks. Our results
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Figure 6 Ratio of the proportion of a haplotype tagged by htSNPs ( ) containing the major alleles ( ) of an uncommon SNP to the¯A Xj
proportion of the same haplotype containing the minor alleles (X)—that is, the ratio .¯P(A dX)/P(A dX)j j
support the hypothesis that only infrequent recombina-
tions occur within haplotype blocks and that out-of-block
regions, but not block regions, include recombinational
“hotspots.”
Information about SNPs and their frequency in drug-
related genes will be very important for population-
based pharmacogenetic studies, as well as for the de-
velopment of personalized drug therapy. Our results,
which are summarized as the statistics for 4,104 au-
tosomal SNPs in ﬁgure 2, can suggest a method for
the optimization of population-based pharmacogenetic
studies. Thus, from 3,244 common SNPs, we could se-
lect 1,035 htSNPs (31.9%) that represent most of the
major haplotypes within the blocks. Because ∼64.2%
of uncommon SNPs were within such blocks and the
majority of their minor alleles were assigned to single
incomplete haplotypes deﬁned by htSNPs, these 1,035
htSNPs can be used to search for both common and
uncommon SNPs associated with phenotypes if the phe-
notype-related SNPs are within the blocks. Only 112
(3.5%) of 3,244 common SNPs were located outside of
the blocks (ﬁg. 2), and we can use all of these to search
for phenotype-related common SNPs located outside of
the blocks. Therefore, for optimal population-based
pharmacogenetic studies, genotyping a total of 1,147
( ) common SNPs is required, which rep-1,035 112
resents ∼35.2% (1,144/3,244) of all of the common
SNPs found (ﬁg. 2).
It is obvious that the most difﬁcult problem is un-
common SNPs that are phenotype-related and located
outside of the blocks. Some of these may be in weak
LD with adjacent out-of-block common SNPs and may
be detected using out-of-block common SNPs as tags.
However, the power of this method should not be high.
An international project to construct a genomewide
haplotype map has been started (the HapMap project)
(Couzin 2002); however, it is focused on common
SNPs. The common SNPs are, of course, very impor-
tant in drug reactions. However, uncommon SNPs are
also likely to be important, especially for uncommon
severe adverse reactions. For example, if an uncom-
mon nonsynonymous SNP is responsible for a severe
adverse reaction, then the frequency of a major hap-
lotype to which most of the minor alleles of the un-
common SNP are assigned may have increased among
the affected subjects. Such a haplotype may be iden-
tiﬁed using htSNPs.
Thus, we have provided a database of SNPs and hap-
lotype blocks of 199 drug-related genes using samples
from 752 subjects. During the analysis of the data, we
noticed, using the programs for haplotype inference,
that most of the minor alleles of each uncommon SNP
within a block are assigned to a single haplotype. These
data suggest that the construction of haplotype blocks
and the selection of htSNPs may be useful in identifying
not only common SNPs but also unidentiﬁed uncom-
mon SNPs that are associated with phenotypes such as
diseases and drug reactions. Although the results of pre-
vious studies suggested that EM-based haplotype infer-
ence is accurate (Long et al. 1995; Kitamura et al. 2002),
our data are worth being reexamined on the basis of
data from molecular haplotyping. In addition, although
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Figure 7 Probability of the signiﬁcance for the tests comparing the frequencies of the haplotypes tagged by htSNPs between affected and
control populations when the phenotype-associated uncommon SNP differs in frequency between the two populations. The ratio r p P(X d
was set at 8, and the signiﬁcance level was set at .01. The numbers of the subjects in affected and control samples ( and )¯w)/P(X dw) M M1 2
were set at 50 and 500, respectively. The detailed procedure for the simulation is described in appendix A.
we used, as have many other researchers, the threshold
of 0.1 to differentiate common from uncommon SNPs
throughout the present article, the validity of this
threshold should be examined in future studies. Ke et
al. (2004) reported that the pattern of LD changedwhen
the density of SNPs was varied. When they used denser
SNP maps, overall sequence coverage in LD blocks and
block boundaries varied substantially (Ke et al. 2004).
We are now extensively studying the effects of changing
thresholds for differentiating common from uncommon
SNPs on haplotype blocks. When the threshold becomes
lower, the SNP maps become denser. Preliminary results
suggested that a lower threshold leads to the increase
in the overall sequence coverage in haplotype blocks.
The effects of the lower threshold on the lengths of
haplotype blocks seemed complicated. Some blocks be-
came longer because of the addition of new common
SNPs to the boundaries of the blocks, whereas others
became shorter, since the introduction of new common
SNPs resulted in the breakage of the blocks. However,
the assignment of the majority of the minor alleles of
uncommon SNPs within blocks to single haplotypeswas
observed even when the thresholds for differentiating
common from uncommon SNPs were changed from
0.05 to 0.15. Further studies are necessary to determine
the precise effects of the change in the threshold for
differentiating the common from uncommon SNPs.
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Appendix A
In the simulation, the locus involving X, a set of minor alleles of an uncommon SNP within an LD block, was
assumed to be the only locus directly associated with the phenotype. Even though , the htSNP-tagged haplotypeAj
to which the majority of the members of X are assigned, may be associated with (the set of complete haplotypesw
in affected subjects), the association is not direct but instead exists through an association between X and the
phenotype. Because X is associated with the phenotype, the frequencies are expected to be different between affected
and unaffected subjects—that is, , where denotes the complement of . In a case-control study,¯ ¯P(X d w) ( P(X d w) w w
the difference between those frequencies is tested. Let r denote the ratio . We tested whether¯r p P(X d w)/P(X d w)
could be used as an effective marker to detect X. Because the frequencies of X are different between and ¯A w wj
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and is tightly associated with X, the frequencies of are likely to be different between and . The frequencies¯A A w wj j
of are obtained as follows:Aj
¯ ¯P(A d w) p P(X d w)P(A dX,w) P(X d w)P(A dX,w) (A1)j j j
and
¯ ¯ ¯ ¯ ¯¯ ¯P(A d w) p P(X d w)P(A dX,w) P(X d w)P(A dX,w) . (A2)j j j
Because the locus with X is the only locus directly associated with the phenotype, and because the association
between and the phenotype is only through the former association, the following equations hold:Aj
¯P(w dX,A ) p P(w dX,A ) p P(w dX) (A3)j j
and
¯¯ ¯ ¯P(w dX,A ) p P(w dX,A ) p P(w dX) .j j
When Bayes’s theorem is used, the following equation is obtained:
P(A dX)P(w dX,A )j jP(A dX,w) p . (A4)j ¯ ¯P(A dX)P(w dX,A ) P(A dX)P(w dX,A )j j j j
From equation (A3), equation (A4) becomes
P(A dX)P(w dX)jP(A dX,w) p p P(A dX) .j j¯P(A dX)P(w dX) P(A dX)P(w dX)j j
Similarly, we obtain , and . Thus, is independent of¯ ¯¯ ¯ ¯P(A dX,w) p P(A dX) P(A dX,w) p P(A dX,w) p P(A dX) Aj j j j j j
or conditional on X or . This is important, because we calculate and from equations (A1)¯ ¯¯w w X P(A d w) P(A d w)j j
and (A2).
For the simulation in the present study, was used in place of , because we consider the case where¯P(X) P(X d w)
is small and . Thus, the frequency of X in the control group was assumed to be the same as¯P(w) P(X)  P(X d w)
the population frequency. Therefore, equations (A1) and (A2) become
¯P(A d w) p rP(X)P(A dX) [1 rP(X)]P(A dX) (A5)j j j
and
¯ ¯P(A d w) p P(X)P(A dX) [1 P(X)]P(A dX) . (A6)j j j
and for each uncommon SNP were calculated as , and¯¯P(A dX) P(A dX) P(A dX) p P(A ,X)/[P(A ,X) P(A ,X)]j j j j j j
. The procedure to calculate and for each¯ ¯ ¯¯ ¯ ¯ ¯ ¯ ¯P(A dX) p P(A ,X)/[P(A ,X) P(A ,X)] P(A ,X),P(A ,X),P(A ,X) P(A ,X)j j j j j j j j
uncommon SNP within an LD block was as described in the “Material and Methods” section.
Before the simulation, a set of values were given to the ratio r and the numbers of the subjects in the sample,
and . For the simulation, haplotypes were generated for the affected subjects from a binary distributionM M 2M1 2 1
with a frequency parameter of , and haplotypes were generated for the control subjects from a binaryP(A d w) 2Mj 2
distribution with a frequency parameter of . Pearson’s test was used to detect the difference between2¯P(A d w) xj
and , using the contingency table thus obtained. The proportion of the iterations with¯P(A d w) P(A d w) 2 # 2j j
was interpreted as the empirical power. A total of 5,000 iterations was performed for an uncommon SNP.P ! .01
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This test aims to detect the difference between and . Therefore, the ratio plays¯ ¯P(A d w) P(A d w) P(A d w)/P(A d w)j j j j
a critical role. From equations (A5) and (A6), this ratio is
¯1 P(A dX)jr  r[ ]{ }P(X) P(A dX)j
¯P(A d w)/P(A d w) p . (A7)j j
¯1 P(A dX)j1  1[ ]{ }P(X) P(A dX)j
Therefore, the ratio (A7) depends on . When , the ratio (A7) becomes 1,¯ ¯P(A dX)/P(A dX) P(A dX)/P(A dX) p 1j j j j
and one cannot detect the difference between and . The software for the simulation, ANASSIGN,¯P(A d w) P(A d w)j j
written in C language, was written by the authors and will be provided on request.
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